Solid lipid nanoparticles as drug carriers for topical glucocorticoids

Citation
Cs. Maia et al., Solid lipid nanoparticles as drug carriers for topical glucocorticoids, INT J PHARM, 196(2), 2000, pp. 165-167
Citations number
8
Categorie Soggetti
Pharmacology & Toxicology
Journal title
INTERNATIONAL JOURNAL OF PHARMACEUTICS
ISSN journal
03785173 → ACNP
Volume
196
Issue
2
Year of publication
2000
Pages
165 - 167
Database
ISI
SICI code
0378-5173(20000310)196:2<165:SLNADC>2.0.ZU;2-5
Abstract
Recent investigations both in vitro and in human subjects proved the benefi t/risk ratio of prednicarbate (PC) to exceed those of halogenated topical g lucocorticoids about 2-fold. To obtain a further highly desired increase by drug targeting to viable epidermis. PC was incorporated into solid lipid n anoparticles (SLN). Keratinocyte and fibroblast monolayer cultures, reconst ructed epidermis and excised human skin served to evaluate SLN toxicity and PC absorption. Well-tolerated preparations (e.g. cellular viability 94.5%, following 18 h incubation of reconstructed epidermis) were obtained. PC pe netration into human skin increased by 30% as compared to PC cream, permeat ion of reconstructed epidermis increased even 3-fold. The present study sho ws the great potential of SLN to improve drug absorption by the skin. (C) 2 000 Elsevier Science B.V. All rights reserved.